SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-161540
Filing Date
2020-06-05
Accepted
2020-06-05 08:53:33
Documents
8
Period of Report
2020-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d938357d8k.htm 8-K 27026
2 EX-1.1 d938357dex11.htm EX-1.1 155836
3 EX-5.1 d938357dex51.htm EX-5.1 10081
4 EX-99.1 d938357dex991.htm EX-99.1 9685
5 GRAPHIC g938357dsp_41.jpg GRAPHIC 5270
6 GRAPHIC g938357g0605024845343.jpg GRAPHIC 1649
7 GRAPHIC g938357page40a.jpg GRAPHIC 2028
8 GRAPHIC g938357page43a.jpg GRAPHIC 3840
  Complete submission text file 0001193125-20-161540.txt   221954
Mailing Address 490 ARSENAL WAY WATERTOWN MA 02472
Business Address 490 ARSENAL WAY WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38130 | Film No.: 20944747
SIC: 2834 Pharmaceutical Preparations